We are live on ! Find out more
CB

Christopher Bloomstran Semper Augustus Investments Group

AUM $885M
1-Year Est. Return 30.72%
 

Christopher Bloomstran is the president of Semper Augustus Investments Group, a value-oriented firm with a multi-decade focus on capital preservation and thoughtful security selection. He is known for detailed annual letters that discuss portfolio construction, accounting quality, and long-term ownership of businesses such as Berkshire Hathaway. Bloomstran’s work is popular among investors who prefer process transparency over short-term trading narratives.

This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+30.72%
3 Year Est. Return
+95.38%
5 Year Est. Return
+117.62%
10 Year Est. Return
+411.84%
AUM
$130M
AUM Growth
-$3.71M
Cap. Flow
-$2.98M
Cap. Flow %
-2.29%
Top 10 Hldgs %
72.33%
Holding
30
New
2
Increased
3
Reduced
13
Closed
2

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$2.14M
2
SMHI icon
SEACOR Marine Holdings
SMHI
+$1.58M
3
DG icon
Dollar General
DG
+$99.3K
4
XOM icon
ExxonMobil
XOM
+$9.57K
5
MCY icon
Mercury Insurance
MCY
+$57

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$2.47M
2
MRK icon
Merck
MRK
+$2.28M
3
KO icon
Coca-Cola
KO
+$884K
4
CB icon
Chubb
CB
+$820K
5
GE icon
GE Aerospace
GE
+$286K

Sector Composition

Rank Sector Weight
1 Financials 52.55%
2 Materials 10.48%
3 Energy 8.39%
4 Industrials 7.95%
5 Consumer Staples 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DST
26
DELISTED
DST Systems Inc.
DST
$934K 0.72%
15,136
MDT icon
27
Medtronic
MDT
$119B
$444K 0.34%
5,000
RDS.A
28
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$259K 0.2%
4,868
-83
-2% -$4.41K
CB icon
29
Chubb
CB
$132B
-6,018
Closed -$820K
JNJ icon
30
Johnson & Johnson
JNJ
$651B
-19,804
Closed -$2.47M

Similar funds

Christopher Bloomstran's Q2 2017 Portfolio in Review

As of Q2 2017, Christopher Bloomstran held 30 positions worth $130M, down 2.8% from $134M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Christopher Bloomstran's Q2 2017 filing shows 2 new, 3 increased, 13 reduced and 2 closed positions. Its largest new stake was Nike: 39,619 shares worth $2.34M. The largest sale was Johnson & Johnson, an estimated $2.47M.

By sector, the portfolio is most concentrated in Financials at 53% of assets, up from 51% a quarter earlier, followed by Materials and Energy.

  • Christopher Bloomstran's largest Q2 2017 buy was Nike: 39,619 shares worth $2.34M.
  • Christopher Bloomstran added most to Dollar General in Q2 2017, an estimated $99.3K increase.
  • Christopher Bloomstran's biggest Q2 2017 reduction was Merck, cutting an estimated $2.28M.
  • Christopher Bloomstran fully exited Johnson & Johnson in Q2 2017, selling an estimated $2.47M.
  • Christopher Bloomstran's ten largest holdings make up 72% of its $130M portfolio in Q2 2017.
  • Christopher Bloomstran opened 2 new positions and closed 2 in Q2 2017.
  • Christopher Bloomstran's portfolio value fell 2.8% quarter-over-quarter to $130M.

Based on Semper Augustus Investments Group's 13F filing for Q2 2017, filed 11 Aug 2017.